USDM Life Sciences Will Discuss Unique Device Identification and Pharmaceutical Serialization Concerns at GS1 Connect Conference

Share Article

Jay Crowley and Grant Hodgkins to Present at GS1 Connect

News Image

USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, is pleased to announce Jay Crowley, Vice President of UDI Solutions and Services and Grant Hodgkins, Vice President of Commercial Solutions and Services will share their insights regarding current challenges and opportunities in Unique Device Identification (UDI) and Pharmaceutical Track and Trace implementation at the GS1 Connect conference.

Crowley will join the panel at the ‘GS1 Healthcare US Initiative Open Industry Meeting’ (session 148) where he will discuss the latest issues with UDI implementation. The presentation is June 10 at 11 am.

Hodgkins will join a panel at the ‘Assuring Interoperability with Standards in Pharmaceutical Packaging’ (session 147) presentation, where he will share insights on how product barcoding and other GS1 standards are used to drive the accurate and timely exchanges of data necessary to meet current serialization requirements. The presentation is June 12 at 2:40 pm.

At USDM Life Sciences, Crowley focuses exclusively on providing business process, technology and compliance solutions for the regulated life science industry. He was most recently Senior Advisor for Patient Safety in the Food and Drug Administration’s Center for Devices and Radiological Health. Crowley developed the framework and authored key requirements for the FDA’s Unique Device Identification system.

Hodgkins assists USDM Life Sciences clients with Pharmaceutical Track and Trace and a variety of other life science enterprise solutions. Hodgkins has three decades of experience in the life science industry designing, implementing, and managing complex global programs and operations.

GS1 Connect is June 8-12, 2014 at the San Diego Convention Center in San Diego, CA.

About USDM Life Sciences:
USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. USDM Life Sciences has more than 14 years of experience supplying our clients in the life science industry with compliance services during each phase of their drug and product development cycle while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. For more information, please visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ryan Carmel
USDM Life Sciences
+1 805-856-2660
Email >
Visit website